Results 81 to 90 of about 26,893 (258)
For tumor‐stage mycosis fungoides, systemic therapy in combination with skin‐directed local therapy is the mainstay of treatment. Here, we report a case where a tumor‐stage mycosis fungoides of the scalp showed a remarkable response to single fraction ...
Atsuto Katano
doaj +1 more source
STAT5 induces miR-21 expression in cutaneous T cell lymphoma [PDF]
In cutaneous T cell lymphomas (CTCL), miR-21 is aberrantly expressed in skin and peripheral blood and displays anti-apoptotic properties in malignant T cells. It is, however, unclear exactly which cells express miR-21 and what mechanisms regulate miR-21.
Blümel, Edda+25 more
core +2 more sources
Summary Background and Objectives Mycosis fungoides (MF) accounts for the majority of cutaneous lymphomas (CL). There is a documented delay in the diagnosis of early‐stage MF. However, its timely diagnosis is paramount to avoid potentially harmful therapies and undue patient distress.
Paula Beatty+7 more
wiley +1 more source
Increased Expression of Delta-like Ligand 4 in Mycosis Fungoides
In many malignancies, dysregulation of the Notch pathways, composed of 4 Notch receptors (Notch1–4) and 5 Notch ligands (Jagged1–2, Delta-like ligand-1, 3–4), is associated with their development.
Hikari Boki+8 more
doaj +1 more source
Cirulating Sézary Cells in the Diagnosis of Sézary Syndrome (Quantitative and Morphometric Analyses) [PDF]
Plastic-embedded circulating Sézary cells were examined in semithin and thin sections (assisted by the nuclear contour index-NCI). Eight cases of Sézary syndrome were analyzed as well as 11 controls (3 cases of widespread eczemas and 8 cases of ...
Braun-Falco, Otto+3 more
core +1 more source
Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides [PDF]
Mycosis fungoide (MF) patients who develop tumors or extracutaneous involvement usually have a poor prognosis with no curative therapy available so far.
Barranco, Carlos+23 more
core +1 more source
Lymphomatoid Papulosis Following Spesolimab Treatment for Generalised Pustular Psoriasis
Australasian Journal of Dermatology, EarlyView.
Mizuho Namba+6 more
wiley +1 more source
Mogamulizumab induces cytotoxicity against CCR4+ lymphoma cells by antibody-dependent cell-mediated cytotoxicity in advanced cutaneous T-cell lymphoma patients. Since the efficacy of mogamulizumab in mycosis fungoides (28.6%) is lower than that in Sézary
Taku Fujimura+7 more
doaj +1 more source
Langerhans cell hyperplasia in the tumor stage of mycosis fungoides: a mimic of Langerhans cell histiocytosis [PDF]
Mycosis fungoides is a form of cutaneous T-cell lymphoma (CTCL). Malignant CD4+ T cells have been found to adopt the T-regulatory (Treg) cell phenotype and function.
Lin, Tzu-Chun+5 more
core +2 more sources
Methotrexate (MTX) has been a longstanding therapeutic option for mycosis fungoides (MF); however, data on its real‐world effectiveness remain limited. This study aimed to assess real‐world outcomes of oral MTX in the treatment of MF. Data from five referral centres for cutaneous lymphoma in Greece were retrospectively reviewed with the baseline‐ and ...
Vasiliki Nikolaou+21 more
wiley +1 more source